Some people may have many side effects. Others have fewer. Side effects can happen any time during, immediately after or days to months after a stem cell transplant. Short-term acute side effects generally develop during the first days after a stem cell transplant. Long-term chronic side effects generally develop or more days after the transplant.

Breast Cancer: Types of Treatment


You are here
Arimidex chemical name: anastrozole , Aromasin chemical name: exemestane , and Femara chemical name: letrozole are aromatase inhibitors. Ibrance also is approved to be used in combination with the hormonal therapy Faslodex chemical name: fulvestrant to treat advanced-stage or metastatic, hormone-receptor-positive, HER2-negative breast cancer that has grown after being treated with hormonal therapy in women or men. Premenopausal and perimenopausal women who take Ibrance in combination with Faslodex also should be treated with a medicine to suppress ovarian function. Cancer cells grow in uncontrolled fashion. A kinase is a type of protein in the body that helps control cell division. Ibrance also can be used in combination with Faslodex in women or men to treat advanced-stage or metastatic, hormone-receptor-positive, HER2-negative breast cancer that has grown after being treated with hormonal therapy. Advanced-stage breast cancer is cancer that has come back recurred or spread beyond the breast to the chest wall below the breast. Metastatic breast cancer is advanced-stage cancer that has spread to parts of the body away from the breast, such as the bones or liver. Femara, Aromasin, and Arimidex are all aromatase inhibitors, a type of hormonal therapy.
What hormones are
Matcha has skyrocketed in popularity lately, with matcha shots, lattes, teas, and even desserts appearing everywhere from health stores to coffee shops. Like green tea, matcha comes from the Camellia sinensis plant. Farmers grow matcha by covering their tea plants 20—30 days before harvest to avoid direct sunlight.
Hormone-suppression therapies are used for the treatment of breast cancer in the adjuvant and metastatic settings alike. However, side effects—including hot flashes—are frequently reported by patients as a cause of therapy discontinuation. This paper presents an overview of hormonal therapies and the evidence-based management options for hot flashes, summarized in a treatment algorithm. In , an estimated 22, women in Canada were diagnosed with breast cancer, making that disease the most common cancer in women. Treatment includes any combination of surgery, chemotherapy, and radiation therapy. For women with cancers positive for the estrogen or the progesterone receptor or both , hormone suppression is an additional option. Because hormone-suppressive treatment can span five or more years, care is often shared with or transferred to family physicians and community nurse practitioners.